Author:
Jackson Meredith A.,Bedingfield Sean K.,Yu Fang,Stokan Mitchell E.,Miles Rachel E.,Curvino Elizabeth J.,Hoogenboezem Ella N.,Bonami Rachel H.,Patel Shrusti S.,Kendall Peggy L.,Giorgio Todd D.,Duvall Craig L.
Funder
Vanderbilt Hormone and Analytical Services Core
NCI
NIH Cancer Center
Vanderbilt Mouse Metabolic Phenotyping Center
Vanderbilt Ingram Cancer Center
Vanderbilt Digestive Disease Research Center
DOD
NIH
NSF CAREER BMAT
Vanderbilt Engineering and Immunity Pilot and Feasibility Grant
National Science Foundation
Subject
Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering
Reference70 articles.
1. Patisiran, an investigational RNAi therapeutic for patients with hereditary transthyretin-mediated (hATTR) amyloidosis with polyneuropathy: results from the phase 3 APOLLO study (CT.001);Adams;Neurology,2018
2. Delivery of siRNA therapeutics: barriers and carriers;Wang;AAPS J.,2010
3. Current issues of RNAi therapeutics delivery and development;Haussecker;J. Contr. Release,2014
4. Advances in the delivery of RNA therapeutics: from concept to clinical reality;Kaczmarek;Genome Med.,2017
5. Selective MTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival;Werfel,2018
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献